Epidemiology of Major Respiratory Pathogens
- 1 January 2001
- journal article
- review article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 13 (1) , 205-210
- https://doi.org/10.1179/joc.2001.13.supplement-2.205
Abstract
A vast literature attests to the fact that Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis represent the prevailing bacterial pathogens of community-acquired lower respiratory tract infections. Their specific incidence as causative agents of the more common syndromes is known to vary even profoundly, depending on geographic area, and the same holds true for their rates of resistance to antimicrobial drugs. Europe does not escape the threat posed by the present pandemic spread of penicillin resistance in S. pneumoniae although, as expected, some countries like Spain and France are highly affected and others including Germany, Italy, The Netherlands and the Scandinavian region, are relatively spared. In several sites multiple resistance has been described in S. pneumoniae with the most affected drugs being penicillin, the macrolides, co-trimoxazole and tetracycline. In H. influenzae synthesis of beta-lactamases is the main resistance trait expressed. Lack of susceptibility to beta-lactams dictated by a different mechanism remains extremely rare. Large variations in the incidence of this character are apparent when considering European countries. France and Spain are again widely affected while Germany, The Netherlands and Italy display rates of beta-lactamase-positive H. influenzae of about 16%. M. catarrhalis must be considered generally resistant to non-protected aminopenicillins since over 90% of these organisms produce beta-lactamases.Keywords
This publication has 21 references indexed in Scilit:
- Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteriaJournal of Antimicrobial Chemotherapy, 1999
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY ProgramJournal of Clinical Microbiology, 1998
- Introduction: Problems with Antimicrobial Resistance in Gram‐Positive CocciClinical Infectious Diseases, 1998
- Decrease in antibiotic susceptibility or increase in resistance?Journal of Antimicrobial Chemotherapy, 1998
- The Challenges of Emerging Infectious DiseasesJAMA, 1996
- World Health Organization Strategy for Emerging Infectious DiseasesPublished by American Medical Association (AMA) ,1996
- Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspectiveJournal of Antimicrobial Chemotherapy, 1995
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994
- Resistance to AntibioticsScience, 1994
- The management of infections and antibiotic therapy: a European surveyJournal of Antimicrobial Chemotherapy, 1993